|
Volumn 12, Issue 8, 2013, Pages 565-567
|
Revolution dawning in cardiotoxicity testing
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PHENOBARBITAL;
POTASSIUM CHANNEL HERG;
POTASSIUM CHANNEL KCNQ1;
RANOLAZINE;
VERAPAMIL;
ARTICLE;
CALCIUM HOMEOSTASIS;
CARDIOTOXICITY;
ELECTROCARDIOGRAM;
HEALTH PROGRAM;
HEART ARRHYTHMIA;
HEART DEPOLARIZATION;
HEART DISEASE;
HEART MUSCLE CELL;
HEART MUSCLE POTENTIAL;
HIGH THROUGHPUT SCREENING;
HUMAN;
ION CURRENT;
MEDICAL SOCIETY;
NONHUMAN;
PLURIPOTENT STEM CELL;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
QT INTERVAL;
QT PROLONGATION;
REPOLARIZATION;
RISK FACTOR;
SUDDEN CARDIAC DEATH;
TOXICITY TESTING;
ARRHYTHMIAS, CARDIAC;
COMPUTATIONAL BIOLOGY;
DRUG EVALUATION, PRECLINICAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
INTERDISCIPLINARY COMMUNICATION;
MYOCYTES, CARDIAC;
STEM CELLS;
TOXICITY TESTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84881283663
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4083 Document Type: Article |
Times cited : (70)
|
References (0)
|